The infusion of ex vivo activated and expanded CD4+CD25+ immune regulatory cells inhibits graft-versus-host disease lethality

Blood

Volumn 99, Issue 10, 2002, Pages 3493-3499

  Taylor, Patricia A ^a   Lees, Christopher J ^a   Blazar, Bruce R ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; INTERLEUKIN 2 RECEPTOR;

ADOPTIVE IMMUNOTHERAPY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN FUNCTION; ARTICLE; CONTROLLED STUDY; GRAFT REJECTION; GRAFT VERSUS HOST REACTION; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN GRAFT; WHOLE BODY RADIATION;

EID: 0037093217     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V99.10.3493     Document Type: Article

References (32)

1. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases
2. Pathogenesis of post-thymectomy autoimmune gastritis. Identification of anti-H/K adenosine triphosphatase-reactive T cells
3. + T cells inhibit both the induction and effector function of autoreactive T cells and represent a unique lineage of immunoregulatory cells
4. Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation
5. Pathogenesis of post-thymectomy autoimmunity. Role of syngeneic MLR-reactive T cells
6. Interleukin-2 receptor alpha chain regulates the size and content of the peripheral lymphoid compartment
7. + naturally anergic and suppressive T cells: Induction of autoimmune disease by breaking their anergic/suppressive state
8. + immunoregulatory T cells that control autoimmune diabetes
9. + regulatory cells that control intestinal inflammation
10. Tumor rejection by in vivo administration of anti-CD25 (interleukin-2 receptor alpha) monoclonal antibody
11. + T cells: A common basis between tumor immunity and autoimmunity
12. + immune regulatory cells are required for induction of tolerance to alloantigen via costimulatory blockade
13. + T cells with regulatory properties from human blood
14. + t regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of function
15. + immunoregulatory T cells is antigen nonspecific
16. Interleukin-2 programs mouse alpha beta T lymphocytes for apoptosis
17. Induction of activation-driven death (apoptosis) in activated but not resting peripheral blood T cells
18. TCR antigen-induced cell death occurs from a late G1 phase cell cycle check point
19. Non-Fc receptor-binding humanized anti-CD3 antibodies induce apoptosis of activated human T cells
20. + regulatory T cells from human peripheral blood
21. + immunoregulatory cells
22. + cells regulate CD8 cell anergy in neonatal tolerant mice
23. + regulatory T cells is mediated by cell surface-bound transforming growth factor beta
24. Cytokine-induced survival of activated T cells in vitro and in vivo
25. + T-cell subset inhibits antigen-specific T-cell responses and prevents colitis
26. + immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production
27. + regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4
28. Prophylaxis of graft-versus-host disease by administration of the murine anti-IL-2 receptor antibody 2A3
29. Prevention of graft-versus-host disease (GVHD) by elimination of recipient-reactive donor T cells with recombinant toxins that target the interleukin 2 (IL-2) receptor
30. Treatment of acute graft-versus-host disease with methylprednisolone and cyclosporine with or without an anti-interleukin-2 receptor monoclonal antibody. A mutticenter multicenter phase III study
31. Prevention of acute GVHD by in vivo use of anti-interleukin-2 receptor monoclonal antibody (33B3.1): A feasibility trial in 15 patients
32. + T cells with regulatory properties isolated from peripheral blood